Protein scaffold optimizes arrangement of constituent enzymes in indigoidine synthetic pathway to improve the pigment production

Lei Wang,Yue Sun,Di Lv,Bin Liu,Yuekai Guan,Dayu Yu

DOI: https://doi.org/10.1007/s00253-020-10990-5

IF: 5

2020-11-05

Applied Microbiology and Biotechnology

Abstract:Indigoidine is a dark-blue natural pigment with application prospect and synthesized from glutamine (Gln) by series of indigoidine synthetases (IndCs). Indigoidine production can be improved by enhancing Gln pool via supplementing Gln directly or converting metabolism glutamate (Glu) to Gln by glutamine synthetase (GlnA). But, Gln is expensive, and excess Gln inhibits indigoidine production of the recombinant strain. Supplementing Glu instead of Gln may improve the productive and economic efficiency of indigoidine, but the local activities and positions of the indigoidine pathway enzymes GlnA, Sc-IndC, and the helper protein of Sc-IndC (IndB) should be well arranged. We identified the <i>Streptomyces chromofuscus</i> ATCC 49982 derived IndC (Sc-IndC) as an more efficient IndC compared to other IndCs applied for constructing indigoidine-producting strains, and designed series of protein scaffold complexes with architectures of PDZ, SH3, and GBD domains (PxSyG1) to arrange the pathway enzymes. The strain recruiting GlnA, Sc-IndC, and IndB on the PDZ, SH3, and GBD domains of scaffold P1S2G1, respectively, was the most efficient. In the strain, the GlnA supplied sufficient local Gln for Sc-IndC from Glu, and the generated Gln was immediately consumed by Sc-IndC to relieve cell growth inhibition caused by Gln. The optimum Glu concentration (6 g/L) for the strain was higher than those of the strains recruiting Sc-IndC on the GBD domain, which was away from the PDZ domain recruiting GlnA. The highest titer of indigoidine was 12 g/L, which was two folds of the control without scaffold (5.8 g/L). The titer is 5 g/L higher than the control without Glu supplemented (6.9 g/L), meaning that 97% of the supplemented Glu was transformed into indigoidine. The batch fermentation with the optimum strain in a 5-L reactor achieved an indigoidine titer of 14 g/L in 60 h. To our knowledge, this was the most efficient indigoidine productivity achieved so far. The optimization strategies by protein scaffold should be applicative to other pathways with complex substrate demands.

biotechnology & applied microbiology

What problem does this paper attempt to address?

The paper primarily addresses the issue of how to improve the biosynthesis efficiency of indigoidine by optimizing protein scaffolds. Specifically, the research team designed protein scaffolds for the key enzymes in the indigoidine synthesis pathway—glutamine synthetase (GlnA), indigoidine synthase (Sc-IndC), and auxiliary protein (IndB)—to achieve optimal arrangement of these enzymes within the cell, thereby increasing the yield of indigoidine.

The core findings of the study include:
1. **Comparison of indigoidine synthases from different sources**: The production efficiency of indigoidine synthases (Sc-IndC and Sl-IndC) from different strains in Escherichia coli BAP1 was compared, and the results showed that Sc-IndC had higher production efficiency.
2. **Design and application of protein scaffolds**: A series of protein scaffolds containing PDZ, SH3, and GBD domains (PxSyG1) were designed to rationally arrange the positions of GlnA, Sc-IndC, and IndB, improving the conversion efficiency from glutamate (Glu) to glutamine (Gln) and alleviating the inhibitory effect of excess Gln on cell growth.
3. **Optimization of substrate addition concentration**: The effect of different glutamate (Glu) addition concentrations on indigoidine yield was studied, and it was found that adding 6 g/L Glu achieved the highest indigoidine yield (12 g/L).
4. **Optimization of fermentation conditions**: By optimizing fermentation conditions such as inducer concentration, a maximum indigoidine yield of 14 g/L was achieved in a 5 L bioreactor.

In summary, this study optimized the positions of key enzymes in the indigoidine biosynthesis pathway through a protein scaffold strategy, significantly improving the biosynthesis efficiency of indigoidine and providing an important technical foundation for industrial production.